SOTIO Biotech
Website:
SOTIO Biotech
Business Area(s)
Description
SOTIO® is developing cancer immunotherapies that includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a platform to streamline personalized active immune cell therapies and antibody-drug conjugates (ADCs).
Career Page(s)
Company Location(s)
Jankovcova 1518/2
170 00 Prague
Czechia
Hochbergerstr. 60C
4057 Basel
Switzerland
180 Canal St., Suite 300
Boston, MA 02114
United States
No. 50 Liangmaqiao Road
Beijing
100125
China